Amundi

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
3,007
Total Value
13354570899
Accession Number
0000950123-25-005695
Form Type
13F-HR
Manager Name
Amundi
Data Enrichment
94% identified
2,823 identified184 unidentified

Holdings

3,007 positions
Manager:
Search and click to pin securities to the top
OPENLANE, Inc.
Shares:
18(-5.3%)
Value:
$339.0K(-11.9%)
CORVEL CORP
Shares:
3(+0.0%)
Value:
$333.0K(+1.2%)
Brookfield Business Corp
Shares:
13(-31.6%)
Value:
$332.0K(-27.5%)
WERNER ENTERPRISES INC
Shares:
12(+0.0%)
Value:
$328.0K(-23.0%)
LITTELFUSE INC /DE
Shares:
2(+0.0%)
Value:
$325.0K(-31.4%)
Clear Channel Outdoor Holdings, Inc.
Shares:
299(+0.0%)
Value:
$311.0K(-25.2%)
Cullinan Therapeutics, Inc.
Shares:
40(+0.0%)
Value:
$300.0K(-32.6%)
ZIM Integrated Shipping Services Ltd.
Shares:
22
Value:
$297.0K
CRISPR Therapeutics AG
Shares:
9(+0.0%)
Value:
$294.0K(-21.0%)
POWER INTEGRATIONS INC
Shares:
6(-53.8%)
Value:
$269.0K(-66.3%)
Brookdale Senior Living Inc.
Shares:
42(+0.0%)
Value:
$263.0K(+28.3%)
Amplify Energy Corp.
Shares:
75(+0.0%)
Value:
$245.0K(-47.8%)
92206C730
Shares:
1(+0.0%)
Value:
$244.0K(-9.3%)
ESTABLISHMENT LABS HOLDINGS INC.
Shares:
7(+0.0%)
Value:
$237.0K(-28.4%)
Disc Medicine, Inc.
Shares:
5(+0.0%)
Value:
$229.0K(-26.8%)
Loar Holdings Inc.
Shares:
3(-99.5%)
Value:
$227.0K(-99.5%)
VAALCO ENERGY INC /DE/
Shares:
63(+0.0%)
Value:
$217.0K(-20.5%)
Phathom Pharmaceuticals, Inc.
Shares:
42(+0.0%)
Value:
$210.0K(-28.1%)
Dyne Therapeutics, Inc.
Shares:
21(+0.0%)
Value:
$198.0K(-59.1%)
PLIANT THERAPEUTICS, INC.
Shares:
138(+165.4%)
Value:
$181.0K(-72.4%)